glimepiride has been researched along with glucagon in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkan, AG; Ledercq-Meyer, V; Malaisse, WJ; Marchand, J | 1 |
| Geisen, K | 1 |
| Leclercq-Meyer, V; Malaisse, WJ | 1 |
| Gudat, U; Heinemann, L | 1 |
| Ambrosi, F; Cristallini, S; Filipponi, P; Gregorio, F; Santeusanio, F | 1 |
| Aarsen, M; Draeger, KE; Heine, RJ; Martini, C; van der Wal, PS; van Iperen, AM | 1 |
| Cooperberg, BA; Cryer, PE | 1 |
| Ahrén, B; Dejager, S; Ferrannini, E; Foley, JE; Fonseca, VA; Matthews, DR; Zinman, B | 1 |
| Arbeláez, AM; Cryer, PE; Ramanathan, RP | 1 |
| Anastassiadis, E; Diessel, S; Forst, T; Löffler, A; Pfützner, A | 1 |
| Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 1 |
| Davis, SN; Joy, NG; Tate, DB | 1 |
7 trial(s) available for glimepiride and glucagon
| Article | Year |
|---|---|
Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].
Topics: Adult; Blood Glucose; C-Peptide; Exercise; Exercise Test; Female; Glucagon; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Lactates; Lactic Acid; Male; Sulfonylurea Compounds | 1996 |
Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Middle Aged; Pharmaceutical Preparations; Proinsulin; Sulfonylurea Compounds | 1997 |
Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
Topics: Adamantane; Diabetes Mellitus, Type 2; Glucagon; Humans; Hypoglycemic Agents; Metformin; Nitriles; Postprandial Period; Pyrrolidines; Sulfonylurea Compounds; Vildagliptin | 2010 |
Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
Topics: Adult; Blood Glucose; C-Peptide; Diazoxide; Female; Glucagon; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; KATP Channels; Male; Sulfonylurea Compounds; Young Adult | 2011 |
Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Topics: Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Linagliptin; Male; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1; Postprandial Period; Proinsulin; Purines; Quinazolines; Risk Factors; Sulfonylurea Compounds | 2014 |
Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes.
Topics: Adamantane; Adiponectin; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Fats; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Male; Metformin; Middle Aged; Nitriles; Proinsulin; Pyrrolidines; Sulfonylurea Compounds; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Vildagliptin | 2014 |
Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Leptin; Male; Pancreatic Polypeptide; Single-Blind Method; Sulfonylurea Compounds | 2015 |
5 other study(ies) available for glimepiride and glucagon
| Article | Year |
|---|---|
Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
Topics: Animals; Female; Glucagon; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Time Factors | 1991 |
Special pharmacology of the new sulfonylurea glimepiride.
Topics: Administration, Oral; Animals; Blood Glucose; Chemical Phenomena; Chemistry; Dogs; Female; Glucagon; Glucose; Glyburide; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Lactates; Male; Pancreas; Rabbits; Rats; Somatostatin; Sulfonylurea Compounds | 1988 |
Enhancement by succinic acid dimethyl ester of insulin release evoked by D-glucose and glimepiride in the perfused pancreas of normoglycemic and hyperglycemic rats.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Synergism; Female; Glucagon; Glucose; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Rats; Rats, Wistar; Succinates; Sulfonylurea Compounds | 1994 |
Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.
Topics: Animals; Dose-Response Relationship, Drug; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors | 1996 |
Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Eating; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Secreting Cells; Homeostasis; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Reference Values; Signal Transduction; Sulfonylurea Compounds | 2009 |